Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
UnitedHealth Group
(NY:
UNH
)
522.62
-1.13 (-0.22%)
Streaming Delayed Price
Updated: 3:09 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about UnitedHealth Group
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
Peering Into UnitedHealth Group's Recent Short Interest
Today 13:15 EDT
Via
Benzinga
3 Reasons We Love UnitedHealth (UNH)
Today 5:03 EDT
Although the S&P 500 is down 1.7% over the past six months, UnitedHealth’s stock price has fallen further to $523.02, losing shareholders 10.3% of their capital. This was partly driven by its softer...
Via
StockStory
Topics
Stocks
Supply Chain
Exposures
Supply Chain
US Equities
Molina Healthcare (MOH): Buy, Sell, or Hold Post Q4 Earnings?
Today 5:03 EDT
Molina Healthcare has been treading water for the past six months, recording a small loss of 3.6% while holding steady at $329.49.
Via
StockStory
Topics
Supply Chain
Exposures
Supply Chain
$14K Investor In TSLA, NVDA, And QQQ Faces Dilemma – 'Looking To Hold For At Least 10 Years' But Is That A Recipe For Disaster? Reddit Debates
March 29, 2025
Knowing which stocks to hold for the long term and which to sell before they drag down your portfolio is a challenge every investor faces at least once in their journey.
Via
Benzinga
Peering Into UnitedHealth Group's Recent Short Interest
March 12, 2025
Via
Benzinga
UnitedHealth Group Announcement: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
March 28, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
March 28, 2025
Via
The Motley Fool
Topics
ETFs
Economy
Government
Exposures
Economy
Political
Tariff
Want To Buy Stocks In 2025? There's One Conflicting Place To Find Winners, Analyst Says
March 25, 2025
Via
Benzinga
Top Dividend Stocks With Over 10 Years of Hikes—and Room to Grow
March 25, 2025
Via
MarketBeat
Topics
World Trade
Exposures
Tariff
Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers Stocks
March 25, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Economy
Fraud
Exposures
Artificial Intelligence
Interest Rates
Legal
UnitedHealth Group Announces Earnings Release Date
March 24, 2025
From
UnitedHealth Group
Via
Business Wire
Stop Chasing Returns And Start Getting Rising Dividends With These 10 Blue Chip Stocks
March 23, 2025
Instead of chasing returns, investors can start building long-term passive income through dividend growth stocks.
Via
Talk Markets
Topics
Stocks / Equities
Chevron, Fiserv And A Health Care Stock On CNBC's 'Final Trades'
March 21, 2025
Via
Benzinga
UnitedHealth Shares Rise 1.8% After Key Signal
March 21, 2025
A significant trading signal occurred for UnitedHealth stock as it demonstrated a Power Inflow at $505.54, after which UNH rose up to 1.8%.
Via
Benzinga
UnitedHealth Group Announcement: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
March 20, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
March 20, 2025
Via
Benzinga
UnitedHealth To Overhaul Payment Model To Support Independent Pharmacies
March 20, 2025
Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting independent pharmacies nationwide.
Via
Benzinga
Optum Rx to Modernize Pharmacy Payment Models
March 20, 2025
From
Optum
Via
Business Wire
Optum Rx Further Simplifies Consumer Access to Prescription Drugs
March 19, 2025
From
Optum Rx
Via
Business Wire
UnitedHealth Group Announcement: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
March 17, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Dow Jones Stocks: Volatility Highlights and Ones to Watch This Week
March 16, 2025
March 16, 2025 – 1:54 PM PDT The Dow Jones Industrial Average has experienced significant turbulence in recent weeks, driven by economic uncertainty, shifting trade policies, and mixed corporate...
Via
MarketMinute
Topics
Government
Stocks
World Trade
Exposures
Political
Tariff
US Equities
Generate Passive Income From This Low-Cost Vanguard ETF That Is Crushing the S&P 500 in 2025
March 14, 2025
Via
The Motley Fool
Topics
ETFs
Stocks
Exposures
US Equities
These Were the 2 Worst-Performing Stocks in the Dow Jones Industrial Average in February 2025
March 14, 2025
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
$1000 Invested In UnitedHealth Group 10 Years Ago Would Be Worth This Much Today
March 13, 2025
Via
Benzinga
On Sale Now: 20 Blue Chip Stocks to Buy
March 13, 2025
These 20 blue chip companies are the largest traded on U.S. exchanges.
Via
The Motley Fool
AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries
March 12, 2025
From
AM Best
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
March 11, 2025
Via
Benzinga
Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?
March 11, 2025
Vanguard has some excellent dividend ETFs, but they are right for different investors.
Via
The Motley Fool
Topics
ETFs
UnitedHealth Group Incorporated Investor News: UNH Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
March 09, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Vertex Newly Approved Pain Treatment Lands Higher Cost Tier 3 Placement In UnitedHealth's Optum Rx Formularies
March 07, 2025
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
79
80
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.